全文获取类型
收费全文 | 453541篇 |
免费 | 32082篇 |
国内免费 | 7818篇 |
专业分类
耳鼻咽喉 | 5726篇 |
儿科学 | 9152篇 |
妇产科学 | 11212篇 |
基础医学 | 62134篇 |
口腔科学 | 13250篇 |
临床医学 | 39719篇 |
内科学 | 89712篇 |
皮肤病学 | 9324篇 |
神经病学 | 31334篇 |
特种医学 | 16580篇 |
外国民族医学 | 114篇 |
外科学 | 67642篇 |
综合类 | 22558篇 |
现状与发展 | 15篇 |
一般理论 | 75篇 |
预防医学 | 22502篇 |
眼科学 | 11476篇 |
药学 | 39189篇 |
80篇 | |
中国医学 | 6447篇 |
肿瘤学 | 35200篇 |
出版年
2022年 | 2976篇 |
2021年 | 6560篇 |
2020年 | 4639篇 |
2019年 | 5264篇 |
2018年 | 7209篇 |
2017年 | 5876篇 |
2016年 | 5809篇 |
2015年 | 7525篇 |
2014年 | 9942篇 |
2013年 | 11360篇 |
2012年 | 16015篇 |
2011年 | 16535篇 |
2010年 | 10268篇 |
2009年 | 9033篇 |
2008年 | 13753篇 |
2007年 | 14385篇 |
2006年 | 13931篇 |
2005年 | 12962篇 |
2004年 | 11425篇 |
2003年 | 10922篇 |
2002年 | 10332篇 |
2001年 | 29735篇 |
2000年 | 30375篇 |
1999年 | 25404篇 |
1998年 | 6336篇 |
1997年 | 5422篇 |
1996年 | 4769篇 |
1995年 | 4397篇 |
1994年 | 3861篇 |
1993年 | 3309篇 |
1992年 | 16520篇 |
1991年 | 15239篇 |
1990年 | 14514篇 |
1989年 | 14255篇 |
1988年 | 12818篇 |
1987年 | 12305篇 |
1986年 | 11277篇 |
1985年 | 10457篇 |
1984年 | 7005篇 |
1983年 | 5663篇 |
1982年 | 2760篇 |
1979年 | 5508篇 |
1978年 | 3357篇 |
1977年 | 2974篇 |
1975年 | 2644篇 |
1974年 | 3077篇 |
1973年 | 2875篇 |
1972年 | 2839篇 |
1971年 | 2779篇 |
1969年 | 2547篇 |
排序方式: 共有10000条查询结果,搜索用时 18 毫秒
41.
目的观察妇科腹腔镜手术围术期碳水化合物口服疗法和传统禁饮食方案两种不同的临床处理措施对于术后胰岛素抵抗(IR)的影响。
方法选取2018年2月至8月入住徐州医科大学附属医院妇科,行腹腔镜下全子宫切除手术的非糖尿病患者共98例,将采用围术期碳水化合物口服疗法者作为观察组(50例),采用传统禁饮食方案者作为对照组(48例)。检测所有病例的术前、术后第1天及第3天的空腹血糖(FPG)及空腹胰岛素(FINS),并利用稳态模式评估法计算稳态模型胰岛素抵抗指数(HOME-IR)。对于观察组与对照组患者术前、术后第1天和术后第3天的FPG、FINS和HOME-IR等指标,组间比较采用独立样本t检验。两组患者术后腹胀、术后24 h通气、术后发热的发生情况的比较采用确切概率法检验。
结果观察组与对照组比较,术前和术后第1天FPG差异无统计学意义(P均>0.05),术后第3天FPG明显降低[(4.34±0.59)mmol/L vs (4.96±0.64)mmol/L],差异有统计学意义(t=-4.96,P=0.002)。观察组与对照组比较,术前和术后第1天FINS差异无统计学意义(P均>0.05),术后第3天FINS明显降低[(45.39±13.55)mIU/L vs (51.18±9.34) mIU/L],差异有统计学意义(t=-2.46,P=0.033)。观察组与对照组比较,术前HOME-IR差异无统计学意义(P>0.05),术后第1天和术后第3天HOME-IR明显降低[(13.08±4.80)vs (15.03±4.11);(9.37±3.65)vs (11.30±2.55)],差异有统计学意义(t=-0.69,P=0.042;t=-3.99,P=0.033)。两组患者术后其他观察指标比较,观察组术后24 h通气率与对照组比较明显增高(76.0% vs 64.6%),差异有统计学意义(P=0.045)。两组患者在术后腹胀、术后发热的发生率方面差异无统计学意义(P均>0.05)。两组患者均未发生术中误吸。
结论妇科腹腔镜手术围术期应用碳水化合物口服疗法较传统禁饮食方案,能有效减轻术后IR程度,促进术后康复进程,且不增加围术期并发症的发生率。 相似文献
42.
43.
44.
William G. Breen Krishan R. Jethwa Nathan Y. Yu Grant M. Spears William S. Harmsen Robert C. Miller Jonathan B. Ashman William G. Rule Terence T. Sio Michelle A. Neben-Wittich Michael G. Haddock Amit Mahipal Mark J. Truty Christopher L. Hallemeier Kenneth W. Merrell 《Practical radiation oncology》2021,11(1):e63-e69
PurposeOur purpose was to determine the effect of chemoradiotherapy (CRT) on patient-reported quality of life (QOL) for patients with intact pancreas cancer.Methods and MaterialsWe reviewed a prospective QOL registry for patients with intact, clinically localized pancreatic ductal adenocarcinoma treated with CRT between June 2015 and November 2018. QOL was assessed pre-CRT (immediately before CRT, after neoadjuvant chemotherapy) and at the completion of CRT with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and its component parts: FACT-General (FACT-G) and hepatobiliary cancer subscore (HCS). A minimally important difference from pre-CRT was defined as ≥ 6, 5, and 8 points for FACT-G, HCS, and FACT-Hep, respectively.ResultsOf 157 patients who underwent CRT, 100 completed both pre- and post-CRT surveys and were included in the primary analysis. Median age at diagnosis was 65 years (range, 23-90). National Comprehensive Cancer Network resectability status was resectable (3%), borderline resectable (40%), or locally advanced (57%). Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) (75%) or gemcitabine and nab-paclitaxel (42%) were given for a median of 6 cycles (range, 0-42) before CRT. Radiation therapy techniques included 3-dimensional conformal (22%), intensity modulated photon (55%), and intensity modulated proton (23%) radiation therapy to a median dose of 50 Gy (range, 36-62.5). Concurrent chemotherapy was most commonly capecitabine (82%). Sixty-three patients (63%) had surgery after CRT. The mean decline in FACT-G, HCS subscale, and FACT-Hep from pre- to post-CRT was 3.5 (standard deviation [SD], 13.7), 1.7 (SD 7.8), and 5.2 (SD 19.4), respectively. Each of these changes were statistically significant, but did not meet the minimally important difference threshold. Pancreatic head tumor location was associated with decline in FACT-Hep. Nausea was the toxicity with the greatest increase from pre- to post-CRT by both physician-assessment and patient-reported QOL.ConclusionsFor patients with intact pancreatic adenocarcinoma, modern CRT is well tolerated with minimal decline in QOL during treatment. 相似文献
45.
46.
47.
48.
目的:探讨微小RNA-942-5p(miR-942-5p)在肝细胞癌(HCC)组织中的表达及其功能。方法:用实时定量PCR检测西安交通大学第一附属医院样本库保存的73例HCC组织和对应癌旁组织中miR-942-5p的表达。分析miR-942-5p表达与HCC患者临床病理资料的关系,同时分析TCGA数据库中miR-942-5p表达与HCC患者总生存率的关系。Transwell小室检测干扰miR-942-5p表达后HCC细胞迁移和侵袭能力的变化,StarBase V3.0网站和荧光素酶报告基因质粒预测分析miR-942-5p的下游靶点,并用Western blot验证。结果:miR-942-5p表达量在HCC组织中明显高于对应癌旁组织(2.390 vs. 1.764,P0.05)。miR-942-5p表达量与HCC患者肿瘤数目、血管浸润和临床分期明显有关(均P0.05)。miR-942-5p高表达HCC患者总生存率明显低于miR-942-5p低表达HCC患者(19.535%vs. 53.873%,P0.05)。沉默miR-942-5p表达后,肝癌HCCLM3和MHCC97H细胞迁移和侵袭能力明显减弱(均P0.05)。预测与分析结果显示,扣针蛋白5(FBLN5)是miR-942-5p的直接下游靶点(P0.05),沉默miR-942-5p表达导致HCCLM3和MHCC97H细胞中FBLN5表达增加。结论:miR-942-5p在HCC组织中表达异常升高并与恶性临床特征和不良预后密切相关,机制可能与miR-942-5p抑制FBLN5表达促进HCC细胞迁移和侵袭有关。 相似文献
49.
50.
Mariano E. Menendez Suleiman Y. Sudah Patrick J. Denard 《Seminars in Arthroplasty》2022,32(3):644-649
BackgroundThe growing enthusiasm for the use of reverse shoulder arthroplasty (RSA) in the treatment of primary glenohumeral osteoarthritis (GHOA) with an intact rotator cuff is based on data derived from single-center studies with limited generalizability and follow-up. This study compared patient-reported outcomes (PROs) between RSA and total shoulder arthroplasty (TSA) for the treatment of primary GHOA with up to 5-year follow-up and examined temporal trends in the treatment of GHOA between 2012 and 2021.MethodsA retrospective review was performed on patients with primary GHOA undergoing primary arthroplasty surgery from the Surgical Outcomes System global registry between 2012 and 2021. PROs including the American Shoulder and Elbow Surgeons (ASES) score, Single Assessment Numeric Evaluation (SANE) score, and visual analog scale (VAS) for pain were compared between RSA and TSA at 1, 2, and 5 years postoperatively.ResultsA total of 4451 patients were included, with 2693 (60.5%) undergoing TSA and 1758 (39.5%) undergoing RSA. Both RSA and TSA provided clinically excellent outcomes at 1 year postoperatively (ASES: 80.8 ± 17.9 vs. 85.9 ± 15.2, respectively; SANE: 74.8 ± 24.7 vs. 79.5 ± 22.9; VAS pain: 1.3 ± 2.0 vs. 1.1 ± 1.7; all P < .05) that were maintained at 2 years (ASES: 81.3 ± 19.3 vs. 87.3 ± 14.9; SANE: 74.8 ± 26.2 vs. 79.7 ± 24.7; VAS pain: 1.3 ± 2.1 vs. 1.0 ± 1.6; all P < .05) and 5 years (ASES: 81.7 ± 16.5 vs. 86.9 ± 15.3; SANE: 71.6 ± 28.5 vs. 78.2 ± 25.9; VAS pain: 1.0 ± 1.7 vs. 1.0 ± 1.7; all P < .05), with statistical significance favoring TSA. After controlling for age and sex, there was an adjusted difference of 4.5 units in the ASES score favoring TSA (P = .005) at 5 years postoperatively but no differences in adjusted SANE (P = .745) and VAS pain (P = .332) scores. The use of RSA for GHOA grew considerably over time, from representing only 17% of all replacements performed for GHOA in 2012 to nearly half (47%) in 2021 (P < .001).ConclusionRSA as a treatment for GHOA with an intact rotator cuff seems to yield PROs that are largely clinically equivalent to TSA extending to 5 years postoperatively. The observed statistical significance favoring TSA appears to be of marginal clinical benefit based on established minimal clinically important differences and may be a result of the large sample size. Further research using more granular clinical data and examining differences in range of motion and complications is warranted as it may change the value analysis. 相似文献